Abstract
Cancer is a global disease and has a high mortality rate. In recent times, mesoporous silica nanoparticles (MSNPs) (size <500nm) have gained great attention in therapy and diagnosis of cancer because of their viable basic properties suitable for drug delivery, drug targeting, and biomedical imaging. This chapter highlights the advancements of multifunctional MSNPs intended for theranostic applications in cancer. MSNPs are becoming a promising tool for more efficient and safer cancer therapy. However, still there are challenges to bring these nanomaterials in a level of the clinical setting. The pharmacokinetics and toxicokinetics are still challenges to the scientists.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Multifunctional Theranostic Nanomedicines in Cancer
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
